| SCHEDULE OF ACTIVITY RELATED TO SHARES AVAILABLE FOR GRANT UNDER THE 2000 PLAN AND 2010 PLAN |
The
following table summarizes stock option activity for the 2010 Plan during the nine months ended September 30, 2024.
SUMMARY
OF STOCK OPTION ACTIVITY
| | |
| | |
| Options outstanding at December 31, 2023 | |
| 245,154 | |
| Options granted | |
| | |
| Options forfeited or expired | |
| (199,794 | ) |
| Options outstanding at September 30, 2024 | |
| 45,360 | |
|
The
activity related to shares available for grant under the 2010 Plan and the 2019 Plan for the years ended December 31, 2023 and 2022 was
as follows:
SCHEDULE OF ACTIVITY RELATED TO SHARES AVAILABLE FOR GRANT UNDER THE 2000 PLAN AND 2010 PLAN
| | |
2010 Stock Option Plan | | |
2019 Stock Option Plan | | |
Total | |
| Shares available at December 31, 2021 | |
| - | | |
| 248,613 | | |
| 248,613 | |
| Shares added to the plan | |
| - | | |
| - | | |
| - | |
| Options forfeited | |
| 2,650 | | |
| 198,625 | | |
| 201,275 | |
| Options granted | |
| - | | |
| (174,175 | ) | |
| (174,175 | ) |
| Restricted stock units forfeited | |
| - | | |
| 346 | | |
| 346 | |
| Restricted stock units granted | |
| - | | |
| (29,223 | ) | |
| (29,223 | ) |
| Shares expired | |
| (2,650 | ) | |
| (5,754 | ) | |
| (8,404 | ) |
| Shares available at December 31, 2022 | |
| - | | |
| 238,432 | | |
| 238,432 | |
| Shares added to the plan | |
| - | | |
| 333,333 | | |
| 333,333 | |
| Options forfeited | |
| 41,950 | | |
| 250,859 | | |
| 292,809 | |
| Options granted | |
| - | | |
| (397,503 | ) | |
| (397,503 | ) |
| Restricted stock units forfeited | |
| - | | |
| - | | |
| - | |
| Restricted stock units granted | |
| - | | |
| (259,161 | ) | |
| (259,161 | ) |
| Shares expired | |
| (41,950 | ) | |
| (99 | ) | |
| (42,049 | ) |
| Shares available at December 31, 2023 | |
| - | | |
| 165,861 | | |
| 165,861 | |
|
| SCHEDULE OF STOCK OPTION ACTIVITY UNDER 2010 PLAN AND 2019 PLAN |
|
The
stock option activity under the 2010 Plan and the 2019 Plan for the years ended December 31, 2023 and 2022 was as follows:
SCHEDULE
OF STOCK OPTION ACTIVITY UNDER 2010 PLAN AND 2019 PLAN
| | |
Number of Shares | | |
Weighted Average Exercise Price | | |
Aggregate Intrinsic Value | | |
Weighted Average Remaining Contractual Term | |
| Options outstanding at December 31, 2021 | |
| 683,861 | | |
$ | 44.40 | | |
$ | 3,797,181 | | |
| 7.44 | |
| Granted | |
| 174,175 | | |
| 14.17 | | |
| | | |
| | |
| Exercised | |
| (1,533 | ) | |
| 8.13 | | |
| | | |
| | |
| Forfeited | |
| (201,275 | ) | |
| 68.12 | | |
| | | |
| | |
| Options outstanding at December 31, 2022 | |
| 655,228 | | |
| 29.25 | | |
$ | - | | |
| 6.06 | |
| Granted | |
| 397,503 | | |
| 6.57 | | |
| | | |
| | |
| Exercised | |
| - | | |
| - | | |
| | | |
| | |
| Forfeited | |
| (292,809 | ) | |
| 28.90 | | |
| | | |
| | |
| Options outstanding at December 31, 2023 | |
| 759,922 | | |
$ | 17.48 | | |
$ | 113,929 | | |
| 5.37 | |
| | |
| | | |
| | | |
| | | |
| | |
| Shares exercisable: | |
| | | |
| | | |
| | | |
| | |
| December 31, 2023 | |
| 452,606 | | |
$ | 22.57 | | |
$ | 33,073 | | |
| 3.03 | |
| Shares expected to vest: | |
| | | |
| | | |
| | | |
| | |
| December 31, 2023 | |
| 201,328 | | |
$ | 10.31 | | |
$ | 41,992 | | |
| 8.45 | |
|
| SCHEDULE OF ALLOCATION OF EMPLOYEE STOCK-BASED COMPENSATION EXPENSE BY FUNCTIONAL AREA |
SCHEDULE
OF ALLOCATION OF NON-CASH STOCK BASED COMPENSATION EXPENSE BY FUNCTIONAL AREA
| | |
| | |
| | |
| | |
| |
| | |
Three Months Ended | | |
Nine Months Ended | |
| | |
September 30, | | |
September 30, | |
| (in thousands) | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| Cost of revenue | |
$ | 6 | | |
$ | 7 | | |
$ | 32 | | |
$ | 26 | |
| Research and development | |
$ | 46 | | |
$ | 65 | | |
| 136 | | |
$ | 224 | |
| Sales and marketing | |
$ | 95 | | |
$ | (105 | ) | |
| 139 | | |
$ | 19 | |
| General and administrative | |
$ | 232 | | |
$ | 451 | | |
| 556 | | |
$ | 1,033 | |
| Total | |
$ | 379 | | |
$ | 418 | | |
$ | 863 | | |
$ | 1,302 | |
| Stock-based compensation
expense | |
$ | 379 | | |
$ | 418 | | |
$ | 863 | | |
$ | 1,302 | |
|
The
non-cash stock-based compensation expense included in cost of revenue and operating expenses by functional area for the years ended December
31, 2023 and 2022 was as follows:
SCHEDULE
OF ALLOCATION OF EMPLOYEE STOCK-BASED COMPENSATION EXPENSE BY FUNCTIONAL AREA
| | |
Year Ended | |
| | |
December 31, | |
| (in thousands) | |
2023 | | |
2022 | |
| Cost of revenue | |
$ | 33 | | |
$ | 76 | |
| Research and development | |
| 325 | | |
| 177 | |
| Sales and marketing | |
| 47 | | |
| 354 | |
| General and administrative | |
| 1,319 | | |
| 1,807 | |
| Total | |
$ | 1,724 | | |
$ | 2,414 | |
|